Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jaikumar Duraiswamy

Dual Blockade of PD-1 and CTLA-4 Combined With Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors—Response

Cancer Research

Oncology

2014

English

Ex Vivo Analysis of T-Cell Responses to Epstein-Barr Virus-Encoded Oncogene Latent Membrane Protein 1 Reveals Highly Conserved Epitope Sequences in Virus Isolates From Diverse Geographic Regions

English

Related publications

CTLA-4 Blockade Synergizes With Cryoablation to Mediate Tumor Rejection

English

Tumor Vaccines Expressing Flt3 Ligand Synergize With CTLA-4 Blockade to Reject Preimplanted Tumors

Cancer Research

Oncology

2009

English

Correction: TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-Cell Persistence and Rejection of Established Tumors

Cancer Research

Oncology

2017

English

Correction: Durable Therapeutic Efficacy Utilizing Combinatorial Blockade Against IDO, CTLA-4, and PD-L1 in Mice With Brain Tumors

Clinical Cancer Research

Cancer Research

Oncology

2015

English

Interdependent IL-7 and IFN-γ Signalling in T-Cell Controls Tumour Eradication by Combined Α-Ctla-4+α-Pd-1 Therapy

Nature Communications

English

Combination of Chemotherapy and PD-1 Blockade Induces T Cell Responses to Tumor Non-Mutated Neoantigens

Communications Biology

English

CTLA-4 Blockade Plus Adoptive T-Cell Transfer Promotes Optimal Melanoma Immunity in Mice

Journal of immunotherapy (Hagerstown, Md. : 1997)

English

Expression Levels of CD28, CTLA‑4, PD‑1 and Tim‑3 as Novel Indicators of T‑cell Immune Function in Patients With Chronic Hepatitis B Virus Infection

English

MA11.01 Comparative Efficacy of T-Cell Intrinsic Versus Extrinsic PD-1 Blockade to Overcome PD-L1+ Tumor-Mediated Exhaustion

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jaikumar Duraiswamy

Dual Blockade of PD-1 and CTLA-4 Combined With Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors—Response

Ex Vivo Analysis of T-Cell Responses to Epstein-Barr Virus-Encoded Oncogene Latent Membrane Protein 1 Reveals Highly Conserved Epitope Sequences in Virus Isolates From Diverse Geographic Regions

Related publications

CTLA-4 Blockade Synergizes With Cryoablation to Mediate Tumor Rejection

Tumor Vaccines Expressing Flt3 Ligand Synergize With CTLA-4 Blockade to Reject Preimplanted Tumors

Correction: TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-Cell Persistence and Rejection of Established Tumors

Correction: Durable Therapeutic Efficacy Utilizing Combinatorial Blockade Against IDO, CTLA-4, and PD-L1 in Mice With Brain Tumors

Interdependent IL-7 and IFN-γ Signalling in T-Cell Controls Tumour Eradication by Combined Α-Ctla-4+α-Pd-1 Therapy

Combination of Chemotherapy and PD-1 Blockade Induces T Cell Responses to Tumor Non-Mutated Neoantigens

CTLA-4 Blockade Plus Adoptive T-Cell Transfer Promotes Optimal Melanoma Immunity in Mice

Expression Levels of CD28, CTLA‑4, PD‑1 and Tim‑3 as Novel Indicators of T‑cell Immune Function in Patients With Chronic Hepatitis B Virus Infection

MA11.01 Comparative Efficacy of T-Cell Intrinsic Versus Extrinsic PD-1 Blockade to Overcome PD-L1+ Tumor-Mediated Exhaustion